logo
Select company
Select metric
50.85%Cash to Assets Ratio
VS
Market
92
Sector
73
Industry
64
History
10
$ -1Close
$ -1 - $ -1 52-Week Range
Ticker Information

Ticker

SCPH

Company Name

SCPHARMACEUTICALS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

SCPHARMACEUTICALS INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

SCPH - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 80.25M$ 40.81M50.85%
3/31/2025$ 90.96M$ 57.54M63.26%
12/31/2024$ 107.52M$ 75.66M70.36%
9/30/2024$ 125.07M$ 91.48M73.15%
6/30/2024$ 65.46M$ 38.5M58.82%
3/31/2024$ 78.45M$ 58.45M74.5%
12/31/2023$ 94.48M$ 46.81M49.55%
9/30/2023$ 106.1M$ 35.04M33.03%
6/30/2023$ 114.17M$ 71.35M62.49%
3/31/2023$ 127.37M$ 75.45M59.24%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • SCPHARMACEUTICALS INC's latest trailing twelve months (TTM) Cash to Assets stands at 38.01%.
  • Over the past 5 years, SCPHARMACEUTICALS INC's average Cash to Assets has been 66.43%.
  • The median Cash to Assets for SCPHARMACEUTICALS INC during this period was 67.97%
  • SCPHARMACEUTICALS INC reached its highest Cash to Assets over the past 5 years at 94.2%.
  • The lowest Cash to Assets recorded by SCPHARMACEUTICALS INC in the same timeframe 33.03%

SCPHARMACEUTICALS INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
CDXS : CODEXIS INC 20.49%FENC : FENNEC PHARMACEUTICALS INC 41.68%EDIT : EDITAS MEDICINE INC 65.79%XOMA : XOMA ROYALTY CORP 33.63%SPRO : SPERO THERAPEUTICS INC 50.22%FHTX : FOGHORN THERAPEUTICS INC 33.51%CCCC : C4 THERAPEUTICS INC 27.52%OABI : OMNIAB INC 6.37%VYGR : VOYAGER THERAPEUTICS INC 14.53%ENTA : ENANTA PHARMACEUTICALS INC 14.89%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for SCPHARMACEUTICALS INC is calculated as follows: CashnEq [ $ 44.46M ] / Assets [ $ 116.96M ]
(=) Cash to Assets [ 38.01% ]

SCPH - Cash to Assets Ratio, Last 5 years

33.03%

Minimum

Sep 30, 2023

94.2%

Maximum

Dec 31, 2021

66.43%

Average

67.97%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.79% with a standard deviation of 9.55%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.8%
average9.79%
median6.44%
std9.55%